Adherex Technologies - 53 Year Dividend History | FENC
Historical dividend payout and yield for Adherex Technologies (FENC) since 1971. The current TTM dividend payout for Adherex Technologies (FENC) as of November 29, 2024 is $0.00. The current dividend yield for Adherex Technologies as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.166B |
$0.021B |
|
Fennec Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. The Company's products include Eniluracil and Sodium Thiosulfate (STS). Fennec Pharmaceuticals Inc., formerly known as Adherex Technologies Inc., is based in United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
